The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Court-mandated release of unpublished glyphosate studies could ‘reinvigorate’ EU’s Monsanto Roundup controversy

| March 8, 2019

An EU court ruled [March 7] that European lawmakers must be given access to scientific studies examining the safety of glyphosate, a chemical commonly used in pesticides whose possibly carcinogenic nature has raised global controversy.

The ruling by the EU’s General Court could reinvigorate debate over glyphosate in the EU, which has seen an EU-wide petition to ban the product rejected by the bloc’s executive arm and raised questions of transparency.

Four EU lawmakers — Finland’s Heidi Hautala, Hungary’s Benedek Javor, France’s Michele Rivasi and Belgium’s Bart Staes — filed the case in May 2017 against the European Food Safety Authority (EFSA), which had used toxicological and carcinogenic studies to determine the safety of glyphosate, finding that “glyphosate is unlikely to pose a carcinogenic hazard to humans.”

Related article:  Viewpoint: Sri Lanka's glyphosate-kidney disease scare illustrates why science, not politics, should dictate public health policy

While the European Commission used the findings to classify the chemical as safe, lawmakers were denied access to the same studies, based on the argument that it could harm the commercial interests of companies that presented the studies.

With the release of the data, other scientists can also view the procedures and attempt to replicate and verify the conclusions.

Read full, original article: Glyphosate: EU agency must release censored study, court says

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend